STAGING, SCORING AND GRADING OF MEDULLOBLASTOMA A POSTOPERATIVE PROGNOSIS PREDICTING SYSTEM BASED ON THE CASES OF A SINGLE INSTITUTE

被引:51
作者
SURE, U
BERGHORN, WJ
BERTALANFFY, H
WAKABAYASHI, T
YOSHIDA, J
SUGITA, K
SEEGER, W
机构
[1] UNIV FREIBURG,NEUROCHIRURG KLIN,FREIBURG,GERMANY
[2] NAGOYA UNIV,SCH MED,DEPT NEUROSURG,NAGOYA,AICHI 466,JAPAN
关键词
MEDULLOBLASTOMA; PNET-PF; GRADING; PROGNOSIS;
D O I
10.1007/BF01404849
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although recently survival of some medulloblastoma patients increased remarcably, it remains a serious diagnosis in others. In order to predict the postoperative prognosis in patients treated for medulloblastoma, a new staging, scoring and grading system was developed. Sixty-six patients operated on microsurgically between 1975 and 1990 at a single neurosurgical center were fully followed-up. No patient was excluded due to a poor postoperative course. Completion of commonly used radiotherapy protocols was attempted in all patients. Survival of patients was evaluated by the Kaplan-Meier method. The following 5 parameters were selected to define subgroups. patients' age, tumour location and histology, degree of resection and presence or absence of metastases. Patients older than 10 years had a better prognosis than individuals aged 10 or less (p < 0.01), patients with lateral tumours had a better prognosis than patients with midline tumours with brain stem infiltration (p < 0.05), patients with complete tumour resection had a more favourable prognosis than individuals with subtotal (p < 0.01) or partial resection (p < 0.001), patients without metastases at the time of diagnosis had a better prognosis than individuals without such evidence (p < 0.001), patients with the desmoplastic tumour variant had a better prognosis than patients with classical tumour histology (p < 0.01). According to the prognosis of a distinct subgroup, scoring points were distributed which correlated with the degree of inter-subgroup significances. The sum of a single patient's scoring points was called the total score, Based on this score, three groups of prognosis were distinguished. The good prognosis group (n = 29) showed a significantly better survival (p < 0.05) than the moderate prognosis group (n = 26), whereas the moderate prognosis group had a significantly better survival (p < 0.05) than the poor prognosis group (n = 11). A Kaplan-Meier survival rate of 62% was found in patients of the good prognosis group, a rate of 22% in the moderate prognosis group, and a rate of 0% in the poor prognosis group. It is concluded that this new staging, scoring and grading system is a simple and recommendable prognostic system for all patients treated surgically for medulloblastoma.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 47 条
[1]  
ALLEN J, 1981, P AM ASSOC CANC RES, V22, P404
[2]   Medulloblastoma cerebelli - A common type of midcerebellar glioma of childhood [J].
Bailey, P ;
Cushing, H .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1925, 14 (02) :192-224
[3]   MEDULLOBLASTOMAS AND CEREBELLAR SARCOMAS - A CLINICAL SURVEY [J].
BERGER, EC ;
ELVIDGE, AR .
JOURNAL OF NEUROSURGERY, 1963, 20 (02) :139-&
[4]   THE RISKS OF METASTASES FROM SHUNTING IN CHILDREN WITH PRIMARY CENTRAL-NERVOUS-SYSTEM TUMORS [J].
BERGER, MS ;
BAUMEISTER, B ;
GEYER, JR ;
MILSTEIN, J ;
KANEV, PM ;
LEROUX, PD .
JOURNAL OF NEUROSURGERY, 1991, 74 (06) :872-877
[5]  
BERGHORN WJ, 1982, THESIS U DUSSELDORF, P1
[6]   RADIATION TREATMENT FOR MEDULLOBLASTOMA - A 21-YEAR REVIEW [J].
BERRY, MP ;
DEREK, R ;
JENKIN, T ;
KEEN, CW ;
NAIR, BD ;
SIMPSON, WJ .
JOURNAL OF NEUROSURGERY, 1981, 55 (01) :43-51
[7]   A REVIEW OF THE FACTORS INFLUENCING THE PROGNOSIS OF MEDULLOBLASTOMA - THE IMPORTANCE OF CELL-DIFFERENTIATION [J].
CAPUTY, AJ ;
MCCULLOUGH, DC ;
MANZ, HJ ;
PATTERSON, K ;
HAMMOCK, MK .
JOURNAL OF NEUROSURGERY, 1987, 66 (01) :80-87
[8]  
CARRIE C, 1989, B CANCER, V76, P255
[9]   AN OPERATIVE STAGING SYSTEM AND A MEGAVOLTAGE RADIOTHERAPEUTIC TECHNIC FOR CEREBELLAR MEDULLOBLASTOMAS [J].
CHANG, CH ;
HOUSEPIAN, EM ;
HERBERT, C .
RADIOLOGY, 1969, 93 (06) :1351-+
[10]  
CHATTY EM, 1971, CANCER-AM CANCER SOC, V28, P977, DOI 10.1002/1097-0142(1971)28:4<977::AID-CNCR2820280422>3.0.CO